Tumor group | n | Oct positive | MIBG positive |
---|---|---|---|
GEP-NET | 57 | 52 (91.2) | 28 (49.1) |
GE-NET | 46 | 42 (91.3) | 27 (58.7) |
P-NET | 11 | 10 (90.9) | 1 (9.1) |
Foregut GE-NET | 3 | 2 (66.6) | 1 (33.3) |
Midgut GE-NET | 26 | 23 (96.2) | 16 (69.2) |
Hindgut GE-NET | 6 | 5 (83.3) | 1 (16.7) |
GE-NET with undetermined primary | 11 | 10 (90.9) | 7 (63.6) |
LGM GEP-NET | 50 | 48 (96.0) | 28 (56.0) |
HGM GEP-NET | 7 | 4 (57.1) | 0 (0) |
Functional GEP-NET | 27 | 27 (100) | 20 (74.1) |
Nonfunctional GEP-NET | 30 | 25 (83.3) | 8 (26.7) |
Nonfunctional LGM GEP-NET | 23 | 21 (91.3) | 8 (34.8) |
Functional GE-NET with liver metastases | 19 | 19 (100) | 17 (89.5) |
Nonfunctional LGM GE-NET with liver metastases | 10 | 9 (90) | 4 (40) |
LGM = low-grade malignant; HGM = high-grade malignant.
Percentage in parentheses.